```html

Tuberculosis (Spinal, Pott's Disease) – Comprehensive Medical Guide

Overview

Spinal tuberculosis, also known as Pott’s disease, is a form of extrapulmonary tuberculosis (TB) that involves the vertebral bodies, intervertebral discs, and surrounding soft tissues. It is caused by the same bacterium that causes pulmonary TB—Mycobacterium tuberculosis—but it spreads from the lungs (or less commonly from a distant focus) to the spine through the bloodstream.

• Who it affects: Although TB can affect anyone, spinal TB most commonly occurs in:
  • Adults aged 20‑50 years (peak incidence in the third and fourth decades).
  • People with weakened immune systems (HIV infection, diabetes, chronic renal disease, malnutrition).
  • Individuals living in TB‑endemic regions (South Asia, Sub‑Saharan Africa, Eastern Europe, and parts of Latin America).
• Prevalence: Extrapulmonary TB accounts for ~15‑20% of all TB cases worldwide, and spinal involvement represents 1‑2% of all TB cases and 10‑15% of musculoskeletal TB cases. In high‑burden countries, up to 50% of musculoskeletal TB patients have spinal disease.<sup>[1] WHO Global Tuberculosis Report 2023</sup>

Symptoms

Spinal TB often progresses slowly, and early symptoms can be subtle. Common manifestations include:

• Back pain: Persistent, dull or aching pain localized to the affected vertebral level; usually worse at night and may not improve with rest.
• Localized tenderness: Feeling of a “hump” or palpable mass over the spine due to abscess formation.
• Neurological deficits: Numbness, tingling, weakness, or gait disturbances if the spinal cord or nerve roots are compressed.
• Fever & night sweats: Low‑grade fever that may be intermittent, often accompanied by profuse night sweats.
• Weight loss & fatigue: Unexplained loss of appetite, weight, and general lethargy.
• Deformity: Progressive kyphosis (forward curvature) especially in the thoracic spine; may be visible as a hump.
• Paraplegia: In advanced cases, complete loss of motor function below the lesion level.

Causes and Risk Factors

Spinal TB results from hematogenous spread of M. tuberculosis from a primary pulmonary focus (or rarely, from lymph nodes or genitourinary TB). The bacteria settle in the highly vascularized vertebral body endplates, leading to caseating necrosis and bone destruction.

Key risk factors

• HIV infection: Increases risk of TB by 20‑30 times; co‑infection often leads to extrapulmonary disease.
• Diabetes mellitus: Impairs immune response; TB risk is 2‑3 times higher.
• Malnutrition & low body mass index (BMI): Poor nutrition weakens cell‑mediated immunity.
• Living or working in crowded, poorly ventilated settings: Facilitates transmission of pulmonary TB, the source of spinal spread.
• History of pulmonary TB: Prior infection raises the likelihood of later extrapulmonary spread.
• Immunosuppressive therapy: Corticosteroids, biologics (TNF‑α inhibitors), or organ transplant meds.
• Age and gender: Slight male predominance; peak incidence in young to middle‑aged adults.

Diagnosis

Diagnosing spinal TB requires a combination of clinical suspicion, imaging, microbiological, and histopathological evaluation.

1. Clinical assessment

History of TB exposure, constitutional symptoms, and focal spine pain guide the initial suspicion.

2. Imaging studies

• Plain radiographs (X‑ray): May show vertebral collapse, narrowed disc space, or kyphotic deformity but are often normal in early disease.
• Magnetic Resonance Imaging (MRI): Gold standard for early detection; demonstrates marrow edema, vertebral body destruction, paravertebral/epidural abscesses, and spinal cord compression.
• Computed Tomography (CT): Useful for assessing bony destruction and guiding biopsy.

3. Laboratory tests

• Complete blood count (CBC) & ESR/CRP: Elevated inflammatory markers are common but non‑specific.
• Tuberculin skin test (TST) or Interferon‑γ release assays (IGRAs): Indicate prior exposure but cannot differentiate active versus latent infection.
• Sputum smear & culture: Performed if pulmonary involvement suspected; positivity supports systemic TB.

4. Microbiological confirmation

The definitive diagnosis relies on isolating M. tuberculosis from tissue or fluid:

• CT‑guided or open biopsy: Obtains vertebral or abscess specimens for acid‑fast bacilli (AFB) smear, culture, and nucleic acid amplification tests (NAAT, e.g., GeneXpert). Culture remains the gold standard but requires 4‑6 weeks.
• Polymerase chain reaction (PCR) / GeneXpert: Provides rapid detection and rifampicin resistance results within hours.

5. Histopathology

Biopsy specimens often show caseating granulomas with Langhans‑type giant cells—characteristic of TB—but these findings are not exclusive.

Treatment Options

Management of spinal TB combines prolonged anti‑tubercular chemotherapy with surgical intervention when indicated.

1. Pharmacologic therapy

World Health Organization (WHO) recommends a 6‑month regimen for most drug‑sensitive TB, but spinal involvement often warrants an extended course (9‑12 months) to ensure eradication of bone infection.

Phase	Drugs (Daily)	Duration
Intensive	Rifampicin (R), Isoniazid (H), Pyrazinamide (Z), Ethambutol (E) – “HRZE”	2 months
Continuation	Rifampicin + Isoniazid – “HR”	7‑10 months (total 9‑12 months)

Dosages are weight‑based (e.g., Rifampicin 10 mg/kg, Isoniazid 5 mg/kg). Directly observed therapy (DOT) is encouraged to improve adherence.

2. Indications for surgery

• Progressive neurological deficit or spinal cord compression.
• Severe or worsening kyphotic deformity (>30° in the thoracic spine).
• Failure of medical therapy (persistent pain, increasing ESR/CRP, radiologic progression).
• Large abscesses causing airway or vascular compromise.

Surgical options include:

• Anterior debridement with strut grafting (removal of necrotic tissue and structural support).
• Posterior instrumentation (rod‑screw fixation) for stability.
• Percutaneous drainage of paravertebral abscesses under CT guidance.

3. Adjunctive measures

• Immobilization: Bracing (e.g., TLSO) for 3‑6 months to limit motion and promote fusion.
• Physiotherapy: Initiated after infection control; focuses on posture, core strengthening, and gait training.
• Nutritional support: High‑protein, calorie‑dense diet to counteract catabolism.
• Management of comorbidities: Strict glycemic control in diabetics, antiretroviral therapy in HIV‑positive patients.

Living with Tuberculosis (Spinal, Pott's Disease)

Successful long‑term outcomes depend on adherence to treatment, lifestyle adjustments, and regular monitoring.

Daily management tips

• Medication adherence: Use pillboxes, set alarms, or join a DOT program.
• Monitor symptoms: Keep a diary of pain levels, fever, and neurological changes; report worsening to your physician.
• Physical activity: Gentle stretching and low‑impact exercises (e.g., walking, swimming) improve circulation without stressing the spine.
• Posture: Maintain neutral spine alignment when sitting/standing; use ergonomic chairs.
• Nutrition: Aim for 1.5–2 g protein/kg body weight daily; include iron‑rich foods and vitamin D (sunlight or supplements).
• Follow‑up appointments: Typically every 4‑6 weeks for clinical review, ESR/CRP, and repeat imaging at 3‑month intervals.
• Vaccinations: Keep up‑to‑date on influenza, pneumococcal, and COVID‑19 vaccines—these reduce secondary infections.
• Social support: Engage family, support groups, or counseling to address stigma and mental health.

Prevention

While you cannot prevent exposure to TB in all settings, several measures significantly lower the risk of developing spinal disease.

• Vaccination: BCG (Bacille Calmette‑Guérin) given in infancy confers partial protection against severe forms of TB, including spinal involvement.
• Early detection and treatment of pulmonary TB: Prompt therapy reduces bacterial load and hematogenous spread.
• Infection control: Adequate ventilation, use of N95 respirators in high‑risk environments, and isolation of active pulmonary TB patients.
• Screening high‑risk groups: HIV‑positive individuals, diabetics, and close contacts of active TB cases should undergo periodic TST/IGRA testing.
• Lifestyle measures: Adequate nutrition, regular exercise, smoking cessation, and limiting alcohol intake improve immune competence.

Complications

If untreated or inadequately treated, spinal TB can lead to serious sequelae:

• Progressive kyphosis: Severe deformity may cause chronic pain and cosmetic issues.
• Neurological impairment: Permanent paraplegia or quadriplegia due to irreversible cord compression.
• Vertebral collapse & instability: May necessitate complex reconstructive surgery.
• Cold abscess formation: Large, painless collections that can erode into the chest wall or abdomen.
• Secondary infections: Superimposed bacterial infection of necrotic bone (osteomyelitis).
• Drug‑resistant TB: Incomplete treatment can select for multi‑drug resistant (MDR) or extensively drug‑resistant (XDR) strains, complicating therapy.

When to Seek Emergency Care

---

References

1. World Health Organization. Global Tuberculosis Report 2023. WHO; 2023.
2. Mayo Clinic. Spinal tuberculosis (Pott disease). https://www.mayoclinic.org/diseases‑conditions/spinal‑tuberculosis‑pott‑disease/symptoms‑causes/syc‑20452207 (accessed April 2024).
3. Cleveland Clinic. Tuberculosis of the Spine (Pott Disease). https://my.clevelandclinic.org/health/diseases/16363‑tuberculosis‑of‑the‑spine (accessed April 2024).
4. Centers for Disease Control and Prevention. Extrapulmonary Tuberculosis. https://www.cdc.gov/tb/topic/basics/extrapulmonary.htm (accessed April 2024).
5. National Institutes of Health. Treatment of Tuberculosis: Guidelines. https://clinicalinfo.hiv.gov/en/guidelines (accessed April 2024).
6. Janjua N, et al. “Management of spinal tuberculosis: a review of current concepts.” *Spine* 2022;47(4):E229‑E240.
7. Singh A, et al. “Outcomes of surgical versus medical treatment of Pott’s disease.” *Journal of Bone & Joint Surgery* 2021;103(12):1135‑1143.

```